| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9414966AGB9414966D0 (en) | 1994-07-26 | 1994-07-26 | Pharmaceutical compositions for the nasal administration of antiviral agents |
| PCT/GB1995/001735WO1996003142A1 (en) | 1994-07-26 | 1995-07-24 | Drug delivery composition for the nasal administration of antiviral agents |
| Publication Number | Publication Date |
|---|---|
| GB9700817D0 GB9700817D0 (en) | 1997-03-05 |
| GB2305606A GB2305606A (en) | 1997-04-16 |
| GB2305606Btrue GB2305606B (en) | 1998-08-05 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB9414966APendingGB9414966D0 (en) | 1994-07-26 | 1994-07-26 | Pharmaceutical compositions for the nasal administration of antiviral agents |
| GB9700817AExpired - Fee RelatedGB2305606B (en) | 1994-07-26 | 1995-07-24 | Drug delivery composition for the nasal administration of ICAM-1 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB9414966APendingGB9414966D0 (en) | 1994-07-26 | 1994-07-26 | Pharmaceutical compositions for the nasal administration of antiviral agents |
| Country | Link |
|---|---|
| EP (1) | EP0773791A1 (en) |
| JP (1) | JPH10506376A (en) |
| CA (1) | CA2195639A1 (en) |
| FI (1) | FI970331L (en) |
| GB (2) | GB9414966D0 (en) |
| NO (1) | NO970252D0 (en) |
| WO (1) | WO1996003142A1 (en) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2141076T3 (en) | 1988-09-01 | 2000-03-16 | Bayer Ag | HUMAN RHINOVIRUS RECEPTOR PROTEIN INHIBITING VIRUS INFECTIVITY. |
| US5879712A (en)* | 1995-06-07 | 1999-03-09 | Sri International | Method for producing drug-loaded microparticles and an ICAM-1 dosage form so produced |
| DE69722594T2 (en)* | 1996-03-06 | 2004-04-29 | Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield | POWDERED MEDICINAL PRODUCT CONTAINING INTERCELLULAR ADHESIVE MOLECULE |
| GB9700624D0 (en) | 1997-01-14 | 1997-03-05 | Danbiosyst Uk | Drug delivery composition |
| GB9707934D0 (en)* | 1997-04-18 | 1997-06-04 | Danbiosyst Uk | Improved delivery of drugs to mucosal surfaces |
| US6391452B1 (en) | 1997-07-18 | 2002-05-21 | Bayer Corporation | Compositions for nasal drug delivery, methods of making same, and methods of removing residual solvent from pharmaceutical preparations |
| WO1999003452A1 (en)* | 1997-07-18 | 1999-01-28 | Bayer Corporation | Methods of removing residual solvent from nasal drug delivery compositions |
| JP2004500305A (en)* | 1997-10-31 | 2004-01-08 | フアルマシア・コーポレーシヨン | Sustained-release composition containing gellan gum gel |
| JP4754067B2 (en)* | 1997-12-02 | 2011-08-24 | アルキメデス ディヴェロプメント リミテッド | Composition for nasal administration |
| GB0015682D0 (en)* | 2000-06-28 | 2000-08-16 | Bristol Myers Squibb Co | Sprayable wound care composition |
| RU2185822C2 (en)* | 2000-08-01 | 2002-07-27 | Общество с ограниченной ответственностью "Фармаген" | Preparation for treatment and prophylaxis of viral diseases |
| GB2378383A (en)* | 2001-06-06 | 2003-02-12 | Gursharan Moonga | Nasal delivery of pharmaceutical compositions in powder form |
| GB0300531D0 (en) | 2003-01-10 | 2003-02-12 | West Pharm Serv Drug Res Ltd | Pharmaceutical compositions |
| GB0328186D0 (en) | 2003-12-05 | 2004-01-07 | West Pharm Serv Drug Res Ltd | Intranasal compositions |
| GB0403938D0 (en)* | 2004-02-21 | 2004-03-24 | West Pharm Serv Drug Res Ltd | Chitosan containing solution |
| US20100028447A1 (en) | 2007-01-22 | 2010-02-04 | Targacept, Inc. | Intranasal, Buccal, And Sublingual Administration Of Metanicotine Analogs |
| DE102008007759B4 (en) | 2007-12-04 | 2009-09-24 | Atlantichem Gmbh | Agent for preventing discoloration when washing textiles |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0314863A2 (en)* | 1987-11-02 | 1989-05-10 | Baylor College Of Medicine | Use of ICAM-1 or its functional derivatives for the treatment of non-specific inflammation |
| EP0362531A1 (en)* | 1988-09-01 | 1990-04-11 | Bayer Corporation | A human rhinovirus receptor protein that inhibits virus infectivity |
| WO1990005522A1 (en)* | 1988-11-17 | 1990-05-31 | Per Prisell | Pharmaceutical preparation |
| WO1991006282A1 (en)* | 1989-11-04 | 1991-05-16 | Danbiosyst Uk Limited | Small particle drug compositions |
| WO1993006842A1 (en)* | 1991-10-02 | 1993-04-15 | Boehringer Ingelheim Pharmaceuticals, Inc. | Use of intercellular adhesion molecules, and their binding ligands in the treatment of asthma |
| WO1994000485A1 (en)* | 1992-06-22 | 1994-01-06 | Miles Inc. | Multimeric forms of human rhinovirus receptor protein |
| WO1994027576A1 (en)* | 1993-05-20 | 1994-12-08 | Danbiosyst Uk Limited | Nasal drug delivery composition containing nicotine |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4946870A (en)* | 1986-06-06 | 1990-08-07 | Union Carbide Chemicals And Plastics Company Inc. | Delivery systems for pharmaceutical or therapeutic actives |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0314863A2 (en)* | 1987-11-02 | 1989-05-10 | Baylor College Of Medicine | Use of ICAM-1 or its functional derivatives for the treatment of non-specific inflammation |
| EP0362531A1 (en)* | 1988-09-01 | 1990-04-11 | Bayer Corporation | A human rhinovirus receptor protein that inhibits virus infectivity |
| WO1990005522A1 (en)* | 1988-11-17 | 1990-05-31 | Per Prisell | Pharmaceutical preparation |
| WO1991006282A1 (en)* | 1989-11-04 | 1991-05-16 | Danbiosyst Uk Limited | Small particle drug compositions |
| WO1993006842A1 (en)* | 1991-10-02 | 1993-04-15 | Boehringer Ingelheim Pharmaceuticals, Inc. | Use of intercellular adhesion molecules, and their binding ligands in the treatment of asthma |
| WO1994000485A1 (en)* | 1992-06-22 | 1994-01-06 | Miles Inc. | Multimeric forms of human rhinovirus receptor protein |
| WO1994027576A1 (en)* | 1993-05-20 | 1994-12-08 | Danbiosyst Uk Limited | Nasal drug delivery composition containing nicotine |
| Title |
|---|
| Nature Vol. 344 1990. Marlin S et. al. pages 70-72* |
| Trends in Biotechnology Vol. 9(8) 1991. ILLUM L pages 285 & 288* |
| Publication number | Publication date |
|---|---|
| GB9700817D0 (en) | 1997-03-05 |
| FI970331A7 (en) | 1997-01-27 |
| GB2305606A (en) | 1997-04-16 |
| NO970252L (en) | 1997-01-21 |
| NO970252D0 (en) | 1997-01-21 |
| CA2195639A1 (en) | 1996-02-08 |
| EP0773791A1 (en) | 1997-05-21 |
| AU707462B2 (en) | 1999-07-08 |
| WO1996003142A1 (en) | 1996-02-08 |
| GB9414966D0 (en) | 1994-09-14 |
| FI970331A0 (en) | 1997-01-27 |
| JPH10506376A (en) | 1998-06-23 |
| FI970331L (en) | 1997-01-27 |
| AU2988695A (en) | 1996-02-22 |
| Publication | Publication Date | Title |
|---|---|---|
| GB2303064B (en) | Medicament for nasal administration | |
| HRP960300B1 (en) | Inhaler for administration of blister-packed medicaments | |
| FI955583L (en) | Nasal drug delivery composition containing nicotine | |
| IL116433A0 (en) | Intravaginal drug delivery devices for the administration of 17B-oestradiol precursors | |
| AU1529397A (en) | Delivery system for localized administration of medicaments to the upper respiratory tract | |
| IL127572A (en) | Pharmaceutical composition and medicament for nasal administration | |
| HUP0002645A3 (en) | Phospholipid containing pharmaceutical composition for treating sleep apnea and apparatus for enabling the administration thereof | |
| GB2305606B (en) | Drug delivery composition for the nasal administration of ICAM-1 | |
| ZA965607B (en) | Drug delivery compositions for improved stability of steroids | |
| EP0769973A4 (en) | Intrapulmonary drug delivery within therapeutically relevant inspiratory flow/volume values | |
| ZA9710994B (en) | Pharmaceutical formulations for sustained drug delivery | |
| GB9120024D0 (en) | Nasal pharmaceutical composition | |
| AU4534593A (en) | Compositions and methods for enhanced drug delivery | |
| EP0707471A4 (en) | Novel therapeutic drug delivery systems | |
| HUP0101293A3 (en) | Aspb28-human insulin comprising pharmaceutical composition administered by inhalation and their use | |
| EP0817655A4 (en) | Intrapulmonary delivery of hematopoietic drug | |
| GB9701904D0 (en) | A system for the delivery of drugs and therapeutic agents | |
| GB9418064D0 (en) | Medicament administration inhaler | |
| HUP9900751A3 (en) | Stable pharmaceutical forms of administration containing parathormone | |
| GB9014871D0 (en) | Drug delivery system for administering growth factor | |
| GB2333042B (en) | Colonic delivery of weak acid drugs | |
| ZA984832B (en) | Pharmaceutical form for the administration of paclitaxel process for the preparation of a ready-to-use paclitaxel composition and use of this composition | |
| GB9404293D0 (en) | Drug delivery system | |
| ZA9510787B (en) | Intravaginal drug delivery devices for the administration of 17 beta-oestradiol precursors | |
| GB9626012D0 (en) | Colonic drug delivery composition |
| Date | Code | Title | Description |
|---|---|---|---|
| PCNP | Patent ceased through non-payment of renewal fee | Effective date:20050724 |